latest blog entries
Loading...
Branding...
latest headlines for company on cafepharma
Yahoo
Fri, 11/09/12 - 12:11 pm
Yahoo/Business Wire
Sun, 06/03/12 - 12:42 pm
Seeking Alpha
Thu, 05/24/12 - 12:53 pm
Seeking Alpha
Tue, 12/20/11 - 11:54 am
Seeking Alpha
Fri, 08/26/11 - 9:16 am
tags: Apricus Biosciences, CytRx, Dendreon, Geron, ImmunoCellular, SIGA
Yahoo/Zacks
Sat, 08/13/11 - 2:17 pm
Seeking Alpha
Thu, 06/16/11 - 11:31 am
tags: Antigenics, Biovest International, cancer, CytRx, Dendreon, ImmunoCellular, Keryx, Oncothyreon, vaccines
Seeking Alpha
Tue, 06/14/11 - 9:11 am
Seeking Alpha
Sun, 06/12/11 - 10:45 am
Motley Fool
Tue, 05/31/11 - 12:36 pm
tags: Alnylam, Biogen Idec, biotech, CytRx, Exelixis, GSK, Immunogen, investors, JNJ, Novavax, Pfizer, Seattle Genetics, Vertex Pharmaceuticals
Seeking Alpha
Fri, 05/20/11 - 12:19 pm
Seeking Alpha
Wed, 05/18/11 - 11:43 am
Last 30 twitter posts
-
#MarcumMicroCap - #CytRX to present May 30 Grand Hyatt NYC 110+ presenting companies t.co/cwoz0AAbMs t.co/pzBuQXZ885
-
Edison Investment CytRx Focus on aldoxorubicin t.co/GDdhhSvoxt
-
RT @marcusleroux: Baffling email subjects of the day: "CytRx Corporation - Focus turns to aldoxorubicin", "Bank Vozrozhdenie's 1Q13 IFRS results mixed"
-
RT @marcusleroux: Baffling email subjects of the day: "CytRx Corporation - Focus turns to aldoxorubicin", "Bank Vozrozhdenie's 1Q13 IFRS results mixed"
-
RT @marcusleroux: Baffling email subjects of the day: "CytRx Corporation - Focus turns to aldoxorubicin", "Bank Vozrozhdenie's 1Q13 IFRS results mixed"
-
Baffling email subjects of the day: "CytRx Corporation - Focus turns to aldoxorubicin", "Bank Vozrozhdenie's 1Q13 IFRS results mixed"
-
News: CytRx to Present at the Marcum MicroCap Conference: CytRx Corporation NASDAQ CYTR a biopharmaceuti... t.co/yVeGkhzK6R
-
CytRx to Present at the Marcum MicroCap Conference - CytRx Corporation NASDAQ CYTR a biopharmaceutical resea... t.co/MJftLwU5hH
-
CytRx to Present at the Marcum MicroCap Conference t.co/N5P4mNfobx
-
CytRx to Present at the Marcum MicroCap Conference t.co/RLQSZhqKR5 #biotech
-
CytRx to Present at the Marcum MicroCap Conference t.co/px5upbtuio
-
News: CytRx to Present at the Marcum MicroCap Conference: CytRx Corporation NASDAQ CYTR a biopharmaceuti... t.co/mIb1uxlaoN
-
CytRx to Present at the Marcum MicroCap Conference t.co/oLIsbN9gEh
-
CytRx to Present at the Marcum MicroCap Conference t.co/58JpwWO1Hd
-
$CYTR CytRx to Present at the Marcum MicroCap Conference.. t.co/t8rlJhCnMo
-
CytRx Offers Initial Results from Aldoxorubicin Trial; Abbott Announces CE Mark for World's Longest Coronary D... t.co/ecl84U4ELi
-
CytRx announces data from Phase 1b trial of aldoxorubicin: Yahoo/Fly on the Wall Tue, 05/21/13 - 12:13 pm t.co/zcPBbZcNfD
-
CytRx announces data from Phase 1b trial of aldoxorubicin via Latest Headlines from Cafepharma - ... t.co/VClxscZa0o
-
OCBN Feed: CytRx Corporation Announces Initial Results From Pharmacokinetics Clinical Trial With Aldoxorubicin... t.co/43sa4VE7xu
-
$CYTR: CytRx announces initial results from pharmacokinetics clinical trial with aldoxorubicin in solid tumors;... t.co/BR4xOXvy5l
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors t.co/pQfzvDb2pW
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors t.co/l9CcUq9gZc
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors t.co/DMdL57Qtcu
-
CytRx announces data from Phase 1b trial of aldoxorubicin: t.co/w5xbrj0Ss6
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors: [Busi... t.co/obnY96CDVB
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors: Aldox... t.co/3KHHxUg1jt
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors t.co/l5YMlcri4e
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors t.co/sJZx4eUhqo
-
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors t.co/QyNajaQZpm
-
CytRx Offers Initial Results from Trial with Aldoxorubicin in Solid Tumors t.co/brE9sd685F $CYTR
